About Almac Diagnostics

Almac Diagnostics is a precision medicine company, focused on the discovery, development and commercialisation of complex diagnostic tests.

The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years. The Almac Diagnostics leadership team have worked on many key projects together for over a decade, in partnership with global pharma and biotech clients.

Our senior leadership team are also extremely well networked within industry and academia.

As part of the wider Almac Group, we are a stable, privately owned business that is growing globally in line with increased customer demand. Our diagnostic experience spans oncology, immunology, CNS, and infective diseases.

Customised CDx

We know that when it comes to the discovery, development and commercialisation of companion diagnostics for future precision medicines, no two pharmaceutical or biotech companies will ever have the same needs.

At Almac Diagnostics, we understand these needs: timelines can be challenging, platform flexibility may be required, regulatory approaches may vary and clinical studies often require bespoke methodologies.

Our Customised CDx approach has been designed to offer you an intuitive partnership, with a range of flexible options and specialist supporting services, tailored to your specific drug and companion diagnostic development requirements.

Working with companies worldwide, we create and deliver CDx solutions that are unique – helping you to differentiate your drug in the marketplace.

  • Complex Gene Signatures
  • Multiple Disease Areas
  • Platform Agility
  • Global Lab Facilities
  • Flexible Commercialisation Models